Press Releases

Latest

Imfinzi approved in Japan for unresectable Stage III non-small cell lung cancer
2 July 2018
Bydureon receives positive EU CHMP opinion for new BCise device for patients with type-2 diabetes
29 June 2018
Lynparza significantly delays disease progression in Phase III 1st-line SOLO-1 trial for ovarian cancer
27 June 2018
AstraZeneca to share latest data from an industry-leading portfolio that aims to advance clinical understanding of diabetes and CV risk management at ADA 2018
19 June 2018
Update on Phase III clinical trials of lanabecestat for Alzheimer’s disease
12 June 2018
The EU approves Tagrisso for 1st-line treatment of EGFR-mutated non-small cell lung cancer
8 June 2018
Lynparza in combination with abiraterone delayed disease progression in metastatic castration-resistant prostate cancer
4 June 2018
Moxetumomab pasudotox pivotal data in patients with previously-treated hairy cell leukaemia presented at the 2018 ASCO Annual Meeting
4 June 2018
Update on TERRANOVA Phase III trial for Fasenra in chronic obstructive pulmonary disease
30 May 2018
Imfinzi significantly improves overall survival in the Phase III PACIFIC trial for unresectable Stage III non-small cell lung cancer
25 May 2018

Can't find what you are looking for? Our Press Release archive contains all of our press releases dated before 2011 so you should be able to find just what you are looking for.

Explore archive

Contact us

Karen Birmingham

Director Global Science Media

+44 203 749 5634

Rob Skelding

Director Global Media Relations

+44 203 749 5821

Matthew Kent

Director Global Media Relations

+44 203 749 5906

Gonzalo Viña

Director Global Media Relations

+44 203 749 5916

Jacob Lund

Director External Communications, Sweden

+46 8 553 260 20

Lotta Sjösten

Manager Media Relations, Sweden

+46 8 553 271 10

US Media Team

+1 302 885 2677

Press Releases

Contact us

Subscribe

Follow us

LinkedIn